NIH #R21-OD01830901, and NIH #R21OD02478101 Footnotes DISCLOSURES: JMM previously served as Chief Science Officer and as a member of the Science Advisory Board of LifeVantage Corp., the maker of Protandim, but currently has no relationship or financial interest in the company
The emerging role of dual GLP-1 and GIP receptor agonists in glycemic management and cardiovascular risk reduction
This mechanism functions independently of the canonical GPX4GSH axis, offering a parallel ferroptosis-suppressive pathway
Those reading this protocol should also read the Acetaminophen and NSAID Toxicity protocol, which outlines strategies to avoid the detrimental effects of acetaminophen and NSAIDs
As symptoms, hot flashes usually start about 1-2 years before the onset of menopause (i.e., one year of no periods), and continue for up to five years after menopause, depending on contributing factors
& Cheng, X